Skip to main content
Bayer AG logo

Bayer AG — Investor Relations & Filings

Ticker · BAY ISIN · DE000BAY0017 LEI · 549300J4U55H3WP1XT59 F Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2021-11-09 Interim / Quarterly Rep…
Country DE Germany
Listing F BAY

About Bayer AG

https://www.bayer.com/en/

Bayer AG is a global life science company with core competencies in the fields of healthcare and nutrition. Guided by its mission "Health for all, Hunger for none," the company develops products and services to address fundamental human needs and global challenges. Its operations are divided into three main divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, which offers over-the-counter medications and supplements; and Crop Science, which provides tailored solutions for farmers including seeds, crop protection, and digital farming technologies. Bayer's activities encompass the discovery, development, manufacturing, and commercialization of its product portfolio, aiming to improve quality of life and ensure a sustainable supply of food and feed.

Recent filings

Filing Released Lang Actions
Q3 statement / Q3 financial report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for the third quarter of 2021 for the Bayer Group. It contains detailed financial tables (sales, EBITDA, EBIT, net income, cash flow) and management commentary on financial performance. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full fiscal year and provides substantive financial statements and analysis. Q3 2021
2021-11-09 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Audit Report / Information Classification · 95% confidence The document is a formal announcement ('Bekanntmachung') from Bayer Aktiengesellschaft regarding the fiscal year 2021 (01.01.2021 bis 31.12.2021). It specifically references German commercial code sections (§ 264 Abs. 3, § 264b HGB) concerning the disclosure of financial statements for subsidiaries being included in the consolidated financial statements of the parent company. This type of filing, which relates to the formal publication and disclosure requirements of annual financial information, fits best under the general category of Audit Report / Information (AR) or potentially a specific regulatory filing (RNS). Given that it is a formal disclosure related to the annual financial reporting process (mentioning the consolidated financial statements being published in the Bundesanzeiger), and it is not the full 10-K or a simple earnings release, 'AR' (Audit Report / Information) is the most appropriate fit among the provided options for formal statutory financial disclosures that are not the primary annual report itself. The document length is short (1362 chars) and it announces the status of financial disclosure rather than presenting the full financial data, but it is more specific than a generic RNS. FY 2021
2021-09-06 German
Halbjahresabschluss zum 30.06.2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresabschluss' (Half-Year Financial Report) for Bayer AG for the period ending June 30, 2021. It contains comprehensive financial statements, including income statements, balance sheet data, and detailed management discussion and analysis (Konzernzwischenlagebericht) regarding the company's performance, business segments, and legal risks. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2021
2021-09-03 German
Half-yearly financial report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Year Financial Report 2021' and contains comprehensive financial data, including consolidated income statements, statements of financial position, cash flows, and an interim group management report for the period ending June 30, 2021. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-05 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2021 bis zum 31.05.2021
Governance Information Classification · 92% confidence The document text is very short (863 characters) and appears to be a formal resolution or decision ('Gesellschafterbeschluss') by the sole shareholder of Bayer CropScience Deutschland GmbH regarding the application of specific German commercial code exemptions (§ 264 Abs. 3 HGB) for a short fiscal period ('Rumpfgeschäftsjahr vom 01. Januar bis 31. Mai 2021'). This is a specific corporate governance or legal action document, not a standard financial report (10-K, IR, ER). It details a specific corporate decision related to accounting/reporting requirements, which aligns best with Governance Information (CGR) or potentially a specific legal/corporate action filing. Given the nature of a shareholder resolution concerning accounting exemptions, CGR (Governance Information) is the most appropriate fit among the provided options, as it relates to internal rules and structure, even if it touches on accounting.
2021-08-02 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Regulatory Filings Classification · 95% confidence The document text is very short (684 characters) and appears to be a formal notification related to German accounting law (HGB) concerning the consolidation of a subsidiary (Alcafleu Management GmbH & Co. KG) into the consolidated financial statements of the parent company (Bayer Aktiengesellschaft) for the fiscal year 2021. It explicitly mentions the consolidation exemption under § 264 b HGB and states that the consolidated financial statements will be published in the electronic Federal Gazette (Bundesanzeiger). This structure—a brief notice about the status or publication of a main financial report rather than the report itself—strongly suggests it is an announcement regarding a filing. Since it pertains to the annual financial reporting cycle (mentioning the full fiscal year 2021), but is not the 10-K/Annual Report itself, and it is a formal regulatory notice, the most appropriate classification is Regulatory Filings (RNS) as a general catch-all for formal, short regulatory announcements that don't fit a more specific category like ER or DIV, or Report Publication Announcement (RPA). Given the context of German statutory filings, RNS is often used for miscellaneous regulatory disclosures. However, since it is announcing the status/publication of the consolidated accounts, RPA might also fit, but RNS is safer for general statutory notices not explicitly about the release timing of a known report type. Given the content is a statutory disclosure about consolidation status, RNS is the best fit among the available options for a short, formal regulatory notice.
2021-08-02 German

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.